Vertex Pharmaceuticals Inc
Close on Nov 20, 2026Market cap $130.54BP/E 30.0Yield –
Vertex Pharmaceuticals Total stockholders' equity by Quarter
Total stockholders' equity ($M) ($M)
Vertex Pharmaceuticals Total stockholders' equity: $20,248M in Q2 2026, up 17.9% from a year earlier. That is the highest of the 69 quarters on record here.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K (DB).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total stockholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 20,248 | +17.9% | Form 10-Q (filed 2026-08-04) ↗ |
| Q1 2026 | Mar 31, 2026 | 19,362 | +17.4% | Form 10-Q (filed 2026-05-05) ↗ |
| Q4 2025 | Dec 31, 2025 | 18,666 | +13.7% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 17,319 | +10.8% | Form 10-Q (filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 17,175 | +16.2% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 16,496 | -11.1% | Form 10-Q (filed 2025-05-06) ↗ |
| Q4 2024 | Dec 31, 2024 | 16,410 | -6.7% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2024 | Sep 30, 2024 | 15,631 | -5.3% | Form 10-Q (filed 2024-11-05) ↗ |
| Q2 2024 | Jun 30, 2024 | 14,775 | -4.5% | Form 10-Q (filed 2024-08-02) ↗ |
| Q1 2024 | Mar 31, 2024 | 18,547 | +28.5% | Form 10-Q (filed 2024-05-07) ↗ |
| Q4 2023 | Dec 31, 2023 | 17,580 | +26.4% | Form 10-K (filed 2024-02-15) ↗ |
| Q3 2023 | Sep 30, 2023 | 16,513 | +26.7% | Form 10-Q (filed 2023-11-07) ↗ |
| Q2 2023 | Jun 30, 2023 | 15,470 | +29.6% | Form 10-Q (filed 2023-08-02) ↗ |
| Q1 2023 | Mar 31, 2023 | 14,432 | +32.3% | Form 10-Q (filed 2023-05-02) ↗ |
| Q4 2022 | Dec 31, 2022 | 13,913 | +37.7% | Form 10-K (filed 2023-02-10) ↗ |
| Q3 2022 | Sep 30, 2022 | 13,030 | +36.7% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2022 | Jun 30, 2022 | 11,934 | +29.8% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 10,907 | +21.5% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2021 | Dec 31, 2021 | 10,100 | +16.3% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2021 | Sep 30, 2021 | 9,531 | +17.2% | Form 10-Q (filed 2022-10-28) ↗ |
| Q2 2021 | Jun 30, 2021 | 9,196 | +22.3% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2021 | Mar 31, 2021 | 8,980 | +39.0% | Form 10-Q (filed 2022-05-06) ↗ |
| Q4 2020 | Dec 31, 2020 | 8,687 | +42.8% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 8,134 | +54.8% | Form 10-Q (filed 2020-10-30) ↗ |
| Q2 2020 | Jun 30, 2020 | 7,519 | +48.3% | Form 10-Q (filed 2020-07-31) ↗ |
| Q1 2020 | Mar 31, 2020 | 6,462 | +36.8% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 6,085 | +37.2% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2019 | Sep 30, 2019 | 5,253 | +79.0% | Form 10-Q (filed 2019-10-31) ↗ |
| Q2 2019 | Jun 30, 2019 | 5,070 | +86.7% | Form 10-Q (filed 2019-08-01) ↗ |
| Q1 2019 | Mar 31, 2019 | 4,723 | +94.3% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 4,435 | +117.2% | Form 10-K (filed 2022-02-09) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,935 | +62.7% | Form 10-Q (filed 2018-10-25) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,715 | +45.4% | Form 10-Q (filed 2018-07-26) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,431 | +44.4% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,042 | +52.6% | Form 10-K (filed 2018-02-15) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,803 | +49.2% | Form 10-Q (filed 2017-10-30) ↗ |
| Q2 2017 | Jun 30, 2017 | 1,867 | +59.8% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 1,683 | +50.8% | Form 10-Q (filed 2017-04-28) ↗ |
| Q4 2016 | Dec 31, 2016 | 1,338 | +22.4% | Form 10-K (filed 2017-02-23) ↗ |
| Q3 2016 | Sep 30, 2016 | 1,208 | +12.2% | Form 10-Q (filed 2016-10-31) ↗ |
| Q2 2016 | Jun 30, 2016 | 1,169 | +11.5% | Form 10-Q (filed 2016-08-01) ↗ |
| Q1 2016 | Mar 31, 2016 | 1,116 | +11.9% | Form 10-Q (filed 2016-05-03) ↗ |
| Q4 2015 | Dec 31, 2015 | 1,094 | -0.2% | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | 1,077 | -6.9% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 1,048 | -10.6% | Form 10-Q (filed 2015-08-04) ↗ |
| Q1 2015 | Mar 31, 2015 | 998 | -19.0% | Form 10-Q (filed 2015-05-04) ↗ |
| Q4 2014 | Dec 31, 2014 | 1,096 | -19.2% | Form 10-K (filed 2015-02-13) ↗ |
| Q3 2014 | Sep 30, 2014 | 1,156 | -20.1% | Form 10-Q (filed 2014-11-06) ↗ |
| Q2 2014 | Jun 30, 2014 | 1,172 | -22.3% | Form 10-Q (filed 2014-07-31) ↗ |
| Q1 2014 | Mar 31, 2014 | 1,231 | +31.2% | Form 10-Q (filed 2014-05-05) ↗ |
| Q4 2013 | Dec 31, 2013 | 1,356 | +13.4% | Form 10-K (filed 2014-02-11) ↗ |
| Q3 2013 | Sep 30, 2013 | 1,447 | +18.0% | Form 10-Q (filed 2013-11-07) ↗ |
| Q2 2013 | Jun 30, 2013 | 1,509 | +25.2% | Form 10-Q (filed 2013-08-02) ↗ |
| Q1 2013 | Mar 31, 2013 | 938 | -12.2% | Form 10-Q (filed 2013-05-08) ↗ |
| Q4 2012 | Dec 31, 2012 | 1,196 | +28.8% | Form 10-K (filed 2013-03-01) ↗ |
| Q3 2012 | Sep 30, 2012 | 1,226 | +76.7% | Form 10-Q (filed 2012-11-06) ↗ |
| Q2 2012 | Jun 30, 2012 | 1,206 | +192.0% | Form 10-Q (filed 2012-08-08) ↗ |
| Q1 2012 | Mar 31, 2012 | 1,068 | +172.7% | Form 10-Q (filed 2012-05-10) ↗ |
| Q4 2011 | Dec 31, 2011 | 929 | +84.2% | Form 10-K (filed 2012-02-22) ↗ |
| Q3 2011 | Sep 30, 2011 | 694 | +6.8% | Form 10-Q (filed 2011-11-03) ↗ |
| Q2 2011 | Jun 30, 2011 | 413 | -50.1% | Form 10-Q (filed 2011-08-09) ↗ |
| Q1 2011 | Mar 31, 2011 | 392 | -60.5% | Form 10-Q (filed 2011-05-06) ↗ |
| Q4 2010 | Dec 31, 2010 | 504 | -54.0% | Form 10-K (filed 2011-02-17) ↗ |
| Q3 2010 | Sep 30, 2010 | 650 | – | Form 10-Q (filed 2010-10-28) ↗ |
| Q2 2010 | Jun 30, 2010 | 827 | – | Form 10-Q (filed 2010-08-03) ↗ |
| Q1 2010 | Mar 31, 2010 | 991 | – | Form 10-Q (filed 2010-05-03) ↗ |
| Q4 2009 | Dec 31, 2009 | 1,096 | +358.9% | Form 10-Q (filed 2010-05-03) ↗ |
| Q4 2008 | Dec 31, 2008 | 239 | -11.9% | Form 10-K (filed 2011-02-17) ↗ |
| Q4 2007 | Dec 31, 2007 | 271 | – | Form 10-K (filed 2011-02-17) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Total stockholders' equity ($M), quarterly Q4 2007–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/fs-eq
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.
See a number that looks wrong?